Genmab — Januar 2020
-
-
"Only one dose of daratumumab can decrease the amyloidogenic precursor immunoglobulin light chain protein rapidly and can lead to reversal of organ dysfunction in patients with AL amyloidosis" https://www.news-medical.net/news/20200127/Daratumumab-proves-effective-in-patients-with-relapsed-AL-amyloidosis.aspx
-
God morgen
-
God morgen.
-
God morgen
-
Dr. Shah on Daratumumab-Based Regimens in Frontline Multiple Myeloma https://www.youtube.com/watch?v=nbzuqc5vM5M
-
Chinese Dara dose escalation study Completed
https://clinicaltrials.gov/ct2/history/NCT02852837?A=24&B=25&C=merged#StudyPageTop -
Mayo Dr. Sikander Ailawadh thinks maybe all MM patients needs two "shots" of CLR 131 before any other treatment. All MM patients receiving a split dosing af 37,5 ml CLR 131 in the ph2 Clover 1 trial had disease control and were progression free for 4 month and 50% with a ORR. Interesting to see if repeat dosing can extend durability. Video with Mayo Dr. from ASH commenting on CLR 131. https://www.youtube.com/watch?v=kHFmsr2_9cU&feature=youtu.be
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind